Olanzapine as antiemetic drug in oncology: a retrospective study in non-responders to standard antiemetic therapy

Olanzapine as antiemetic drug in oncology: a retrospective study in non-responders to standard antiemetic therapy. Slimano, F.; Netzer, F.; Borget, I.; Lemare, F.; Besse, B.. Int J Clin Pharm. 2018; : . doi:10.1007/s11096-018-0649-1
Article